Henrik Toft Sørensen, MD, PhD, DMSc, DSc

Professor & Chair
Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark, Midtjylland, Denmark

Regulators and pharmaceutical companies (Contracted Research, Department of Clinical Epidemiology, Aarhus University is partaking in studies with institutional funding, given as research grants to and administered by Aarhus University, including the present study.)

Presentation(s):

• Trends and Prescription Patterns of Medications for Secondary Stroke Prevention in Denmark, 2013—2018

  Friday, August 26, 2022
  6:15 PM – 6:30 PM CEST

• Costs Associated with Healthcare Resources Utilization Among Empagliflozin vs GLP-1RA Initiators in Routine Clinical Care in Denmark

  Friday, August 26, 2022
  6:30 PM – 6:45 PM CEST

• Women's Mortality Following Childbirths Affected by Vaginal Bleeding Due to Threatened Miscarriage: A Danish Cohort Study with up to 40 Years of Follow-up

  Saturday, August 27, 2022
  9:15 AM – 9:30 AM CEST

• Risk of Venous Thromboembolism in Patients Receiving Targeted Anti-cancer Therapy - A Nationwide Cohort Study

  Saturday, August 27, 2022
  1:00 PM – 1:15 PM CEST

• Parity, Use of Statins and Low-dose Aspirin, and Breast Cancer Risk — Data from Two Large Cohort Studies

  Saturday, August 27, 2022
  1:15 PM – 1:30 PM CEST

• High-intensity versus Low- or Moderate-intensity Statin Treatment for Patients with Ischemic Stroke: Nationwide Cohort Study

  Saturday, August 27, 2022
  2:15 PM – 2:30 PM CEST